
Venture capital · Early stage
Catalys Pacific
Catalys Pacific is a transpacific biotech venture firm and company builder with teams in Japan and the United States, creating and funding new therapeutics companies for patients.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Catalys Pacific right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
BetaRounds Catalys Pacific joined, from press and the firm’s own posts.
1 round in the last 12 months
Round sizes, Catalys Pacific’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Catalys Pacific backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Catalys Pacific
Events where Catalys Pacific’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Catalys Pacific is based in Tokyo, Japan. It also has an office in SEATTLE.
3 fund vehicles are on public registers (SEC adviser filings), including CATALYS PACIFIC FUND, LP, CATALYS PACIFIC FUND II, LP and CATALYS PACIFIC PHASE III SELECT FUND, LP.
Stages: Early stage. Sectors: Biotech. From the firm’s own website.
Catalys Pacific lists 3 portfolio companies on its website: Mineralys, Renalys and Pathalys.
Firms whose websites list some of the same companies include RA Capital.
Know before Catalys Pacific’s next round is announced.
PRO tracks Catalys Pacific’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.